Connect with us

Cannabis News

Oregon Cannabis: What to Expect from OLCC This Fall

Published

on


Fall is always eventful in Oregon cannabis. Croptober is an Oregon cannabis tradition— hopefully the crops come in lee of any wildfires. We also have administrative rulemaking annually once summer winds down, typically with public input via multiple rules advisory committees (RACs). That’s what I’m here to discuss.

This year, the Oregon Liquor and Cannabis Commission (OLCC) likely will look at, to start: temporary rules it had adopted under the Governor’s clumsy tax compliance mandate; the 2023 legislative session’s new cannabis laws; leftover business from the 2022 session, and certain COVID-era policies. I say “likely” because the Commission’s call for participation was vague, soliciting only “varied perspectives, backgrounds and expertise.” It did not identify topics for rulemaking.

All of this will take place while new Commission leadership awaits the “audit of the audit” commissioned by the Oregon Department of Justice, and conducted by a Sacramento law firm. Whether and when DOJ will release those findings — on potential corruption in the Secretary of State’s recent review of Oregon’s cannabis program– is anyone’s guess. Fallout from the La Mota scandal continues unabated in any case.

But life must go on. Below are a few of the rulemaking issues I am looking at this fall, following discussion with OLCC.

Tax compliance rules

On June 15, the OLCC approved temporary rules requiring licensed marijuana retailers to obtain a Certificate of Tax (“Certificate”) from the Oregon Department of Revenue (“DOR”), as a condition for acquiring or renewing a marijuana retailer license. A Certificate is also needed for changes of ownership, and for adding someone to a license.

We’re midstream on a couple of business sales where Certificates are required. Believe me when I say the rule can be far-reaching. To the positive, DOR is quick to enlist delinquent taxpayers (on any industry) for payment plans. They want the money after all. But this is all very new to the cannabis space.

An interesting issue to parse in “permanent” rulemaking will be whether OLCC makes tax compliance an annual criterion, or whether licensees will be monitored for noncompliance throughout the year. The former seems more likely. I don’t believe OLCC wants to deal with tax compliance intermittently, especially given the prospect of people falling in and out of compliance with DOR plans. I also don’t expect to see a significant number of license cancellations for noncompliance in this rule’s first year.

Whether or how the temporary rule will be updated is anyone’s guess. I don’t like the rule as it stands today. It was an awkward overreach at a terrible time, and I hope to see things reined in via permanent rulemaking. Once again, the request would simply be for cannabis businesses to be treated similarly to businesses in other industries.

“Basic bill and technical”

Basic bill and technical is a general term for rules needed to implement new cannabis laws passed by the legislature in any given year. At the close of the session in June, I explained that there were three such bills in 2023. Of those three, only HB 2931 should spur RAC activity.

HB 2931 creates a “cannabis reference laboratory to support enforcement of cannabis regulation.” I won’t rehash everything I wrote last month; however, suffice it to say that testing has been in the news a lot lately. This is because of the newish aspergillus testing rules and last week’s petition by various parties at the Oregon Court of Appeal to halt their implementation. Due to this aspergillus saga, I expect the state cannabis lab RAC to garner more attention than it may have.

License reassignment program (social equity)

This one is not being publicized, but I’m told it will happen. This rulemaking will arise from Oregon’s mealy-mouthed HB 4016— a foray into cannabis social equity which doesn’t mention “social equity” or any similar concept. For backstory on this, I would direct you to read Jesse Mondry’s helpful blog post from March of 2022, covering HB 4016 and what it means for OLCC.

I’m advised that OLCC personnel have been in touch with other states recently on cannabis social equity. A big difference between Oregon and many of those states is the Beaver State never got funding. That makes for a heavier lift; but the idea right now is to use criteria from another bill passed in the 2022 legislative session– HB 1579, to implement HB 4016. The former bill, titled the Equity Investment Act, set out “equity risk factors” that conveniently have been vetted by state Department of Justice.

Business Oregon already has distributed money to grantees pursuant to 1579. Using such criteria for OLCC license reassignment under HB 4016 rules would certainly shortcut things. It could also insulate the Commission from litigation and, most importantly, diversify the pool of licensees. That’s the theory anyway.

Drive-up windows; on-site delivery

During COVID, OLCC allowed both walk-up and drive-thru cannabis purchases from licensed retailers. The Commission also relaxed rules around on-site delivery. Eventually, the drive-thru allowance was rescinded, although people still buy and sell cannabis in that manner and OLCC admittedly is not enforcing the drive-thru prohibition. Related to this, OLCC noted last year that was “obvious… that a separate rulemaking process focusing solely on drive-up and delivery rules is needed.”

It’s about that time. I’m hopeful the Commission adopts a permanent rule allowing drive-thru pickup of cannabis, similar to what is allowed with alcohol. The arguments put forth by law enforcement to prohibit drive-thru cannabis purchase simply aren’t convincing. If intoxicated driving isn’t a concern for alcohol pick-up, it shouldn’t be for cannabis.

Miscellaneous topics

I’m setting this out as a category, though I’m not sure what, if anything, will materialize. I’d personally like to see OLCC rulemaking around “temporary authority” for incoming licensees in purchase and sale transactions, similar to what happens on the alcohol side. There is some debate in the Commission about whether this could be done through rulemaking or whether a statutory change is required. Rulemaking here could help deal with the problematic services agreement protocol still utilized in many sales, and OLCC’s disinterest in enforcing any “financial interest” rules related to those agreements— especially for expanding legacy operators.

____________________________________________

If you’re interested in any of the topics covered above, or anything related to Oregon cannabis regulation, consider volunteering your time for one of the OLCC RACs. The application link is here. Note that submissions received before August 8 will receive “priority consideration.” So get ‘em in soon– and enjoy the rest of your summer!



Source link

Cannabis News

Do Psychedelic Mushrooms Have an Entourage Effect Similar to Cannabis?

Published

on

By


psychedelc entrourage effect

Understanding How The Entourage Effect Works In Psychedelic Mushrooms

Learn fascinating ways about how magic mushrooms work!

 

Most of us are already familiar with the entourage effect in marijuana. In essence, the entourage effect means that the therapeutic compounds in cannabis work more efficiently with one another, synergistically, to provide health benefits that are more powerful compared to when we take compounds on its own. While there are cannabis products that isolate THC and CBD, the science tells us that taking flower or full-spectrum form, where other cannabinoids and terpenes are present, are much more effective than one compound on its own.

 

The concept of the entourage effect was discovered in 1999 by none other than Raphael Mechoulam, the famous godfather of THC. Up until recently, most of what we know about the entourage effect has been limited to cannabis plants.


Now, there’s new data suggesting that the same can be observed when medicating with psychedelic mushrooms.

 

After all, psilocybin mushrooms – just like marijuana – also contain a complex array of other compounds, not just the star compound they are known for. While we do have some knowledge of how psilocybin works in the body thanks to clinical tests, keep in mind they do make use of synthesized psilocybin for research most of the time.

 

According to a recent study, psilocybin extracts may have more powerful health benefits for treating depression, OCD, anxiety, and PTSD to name a few because of the other psychoactive as well as non-psychoactive compounds in the mushroom.  “My colleagues and I are very interested in the potential of psychedelics to treat serious, treatment resistant psychiatric disorders such as depression, PTSD, OCD and even schizophrenia,” explains Bernard Lerer, study author and a psychiatry professor and director at the Hadassah BrainLabs Center for Psychedelic Research at Hebrew University.

 

“There are many anecdotal and clinical reports which suggest that extract of psilocybin-containing mushrooms may have unique effects that are qualitatively and quantitatively different from chemical psilocybin, and also some preclinical studies. This observation has important clinical implications and we wanted to test it empirically in a laboratory study,” they said. So for the study, the researchers compared naturally-derived mushroom extracts to chemically made psilocybin, with the intention of discovering whether the other compounds within the extract can provide benefits that are not found when consuming isolated psilocybin.

 

The researchers utilized male adult mice for the trials; they were divided into groups: some were given the naturally occurring mushroom extracts, while the others were given the synthetic psilocybin. Meanwhile, others were given a control solution made of saline. Additionally, the researchers analyzed the heat twitch response (HTR) assay, which is a reputable method for analyzing the impacts of psychedelics on mice. Furthermore, the researchers analyzed the mice in a molecular and biochemical level to understand any synaptic protein expressions within the brain, which are features of neuroplasticity.

 

The results were astonishing: they found that the brains of the mice who were given the naturally occurring mushroom extracts showed more significant neuroplasticity markers through the presence of synaptic proteins, specifically GAP43, SV2A, PSD95, and synaptophysin. Since these proteins are required for development, synaptic growth, and neuroplasticity, these findings suggest that naturally occurring mushroom extracts may indeed have a more powerful impact compared to psilocybin isolate.

 

“Our findings need to be confirmed in human studies but they do suggest that there may be therapeutic advantages to psilocybin-containing mushroom extract over chemically synthesized psilocybin, when both are administered at the same psilocybin dose,” explains Lerer to Psypost.

 

So Much We Need To Uncover In The World Of Mushrooms

 

When magic mushrooms are cultivated and extracted naturally, the sub metabolites of the plant remain intact, unlike the isolated versions that are synthetically produced in a laboratory since it only contains psilocybin.  There are several examples, such as the Baeocystin tryptamine, which can induce mild hallucinogenic effects. Beta-carbolines have also been discovered in psychedelic mushrooms, which can effectively help metabolize psilocin in the human body, causing a more intensive psychedelic experience.


But Why Is It Harder To Study Mushrooms Compared To Marijuana?

 

While the entourage effect of cannabis is already widely studied and better understood, the opposite is true when it comes to psychedelic mushrooms. There’s still so much we need to understand and study better; rodent studies are a start but translating them to humans is a whole other ball game. In addition, other experts have already acknowledged the challenges of identifying such impacts of the entourage effect.

 

For instance, Alan Rockefeller, a renowned mycologist who specializes in DNA sequencing as well as photography of fungi, tells Psychedelic Health: “No one really knows whether the entourage effect occurs with mushrooms.”

He goes on to elaborate the difficulties associated with studying mushrooms: “It is difficult to study because the same batch of mushrooms will have different effects in different people, and the same person on different days,” Rockefeller said. Also, it’s difficult to understand which compounds are active in a plant or mushroom, and how large the impact is for the active compounds. Researchers also need to understand the concentrations of each compound, and how different growing environments or processing can impact it.

 

“There are a dozen different tryptamines that can occur in mushrooms, plus a few beta-carbolines and hundreds of other molecules – so there is probably more than just psilocybin having an effect,” Rockefeller said. “Studying one compound at a time is hard enough, studying mixtures of hundreds of compounds is much more difficult. Without pure compounds, it is difficult to get repeatable results,” Rockefeller said. “It is possible that the therapeutic potential is different depending on the different compounds in the mushrooms. It’s also possible that psilocybin is the only thing that matters, and the other compounds are mostly inactive,” he said.


Conclusion

 

There’s so much yet that we need to know about how psychedelic mushrooms work. However, the possibilities that can be brought about by harnessing the power of the entourage effect in magic mushrooms is incredibly exciting. There is so much potential in this field that we can only truly uncover with more studies.

 

ARE PSYCHEDELICS CANNABIS 2.0? READ ON…

PSYCHEDELICS TRADE SHOW

ARE PSYCHDELICS JUST CANNABIS 2.0? BENZINGA SHOW RECAP!



Source link

Continue Reading

Cannabis News

The Dangers and Effects of THC Vape in UK

Published

on

By


cbd oil vape king UK

People in the UK increasingly realize that CBD vaping is quite safe. Even NHS recommends CBD vaping as one of the relatively safer ways to quit smoking. Vaping is not without any harm, but it is much safer than tobacco smoking. Even more, CBD vaping is associated with some good health effects. However, now people are realizing that THC vape pens could be an even more potent way of enjoying CBD’s health benefits.

What is THC Vape?

If readers noticed that in the introduction of this text, we talked about CBD, there is a reason for that. THC vaping is different from CBD vaping, but not entirely. It has much in common with it.

The hemp plant is rich in many cannabinoids. Two major cannabinoids are THC (Tetrahydrocannabinol) and CBD (Cannabidiol). It also has many minor cannabinoids in smaller amounts, like CBG, CBC, CBN, THCV and CBDV. CBD vape pens generally have all these compounds except THC.

However, THC vape differ in the way that they also contain small amounts of THC along with CBD, minor cannabinoids, and other beneficial organic compounds like terpenes for added flavour and enhanced vaping experience.

So, why do some of the vape pens have added THC in small amounts? After all, THC is known to be addictive and has mind-altering properties. Well, the explanation is simple: the secret is in the dosage. In smaller and legally permitted dosages, THC does not cause a high; it is safe and can have many health benefits.

When small amounts of THC are added to CBD, minor cannabinoids, and terpenes, it results in much more powerful health benefits. That is why some of the CBD-based clinically approved drugs also contain THC.

THC vape pens may also have some distinct benefits not experienced with CBD vape pens. This is due to “the entourage effect.” The entourage effect is a bit different from synergy. Synergy is like two-plus-two equal to five, meaning that using some compounds together results in a more potent effect, yet safety is not compromised. However, the entourage effect means combining two compounds may result in some unique health benefits not seen when those compounds are used in isolation. So, the entourage effect is more powerful and unique than synergy.

Therefore, using THC vape pens means some unique health benefits, although these vape pens contain THC in small amounts.

THC Vape: The Dangers

It is no secret that THC is the main compound responsible for all side effects of the cannabis plant. This substance is addictive and, at higher dosages, causes euphoria, has potent mind-altering properties, and may cause hallucinations.

However, there is one important thing to understand. All these effects of THC are seen at much higher dosages than those in legally produced THC vape pens.

Legally produced/sold vape pens in the UK, like those by CBDoilking, do not contain THC more than 0.2%. This is significantly lower than cannabis indica or marijuana, which may contain 25% or even more THC. So, there is no comparison between legal THC vape pens and marijuana. At these small dosages, THC does not cause euphoria or other side effects and has no addictive properties. It only has mild stress-relief properties at these dosages.

Secondly, THC vape pens sold by CBDoilking follow other important UK guidelines and legal requirements, which means that THC vape pens cannot contain more than 1 mg of THC. Hence, it is not just about low concentration but also about low amounts, thus ensuring its safety.

Safe and Potent THC vape pens

THC vape pens are for health-conscious individuals who would like to vape on a regular basis. It is safe and may have beneficial effects like reduced anxiety, improved mood, and enhanced sleep, and it may also help reduce pain sensation.

THC vape pen is even better than your regular CBD vape pen for quitting smoking. This is because it is better at reducing tobacco cravings.

CBDoilking sells one of the strongest THC vape pens in the market (75-80% CBD plus CBG along with THC in permitted amounts), and yet all pens sold on the platform follow strict legal guidelines. All the products undergo third-party testing and are proven to contain THC, CBD, and other minor cannabinoids within legally permitted and safe limits.

Another good thing about CBDoilking is that these excellent THC vape pens come in many flavours. These flavours are not due to some artificial substances but rather due to their content of terpenes. Terpenes are plant-based aromatic compounds with antioxidant and anti-inflammatory properties.

CBDoilking offers vapes that are based on science, combining different natural compounds in the right ratio. This is both about safety and potency. So, these products are really good for those looking for something better, potent, and yet safe.

The Bottom Line

CBD vape pens have been around for some time, and their safety is well-established. They are an excellent way to quit smoking and also enjoy CBD’s health effects. However, some people are looking for something more potent. THC vape pens are good for such individuals. These contain all beneficial compounds present in the cannabis plant but in the right proportions.

THC vape pen is a new way to enjoy vaping. It is unlikely to cause any side effects as these products are made for regular use. Of course, one should not overdose on THC or CBD. It is important not to have more than a few puffs a day. Rare side effects like nausea or stomach issues might occur but are transient and short-lived. Such issues are rarely the cause of concern, except in a very small number of cases.

Thus, if you are looking for something better to reduce stress and overcome pain and anxiety, then a THC vape pen may be the right choice. Choosing something strong like the one offered by CBDoilking may be a good idea. Despite being strong, these vape pens contain THC only in legally permitted amounts and in concentrations proven to be safe and not cause euphoria.

To sum up, if you are already an experienced CBD vaper, it may be a good idea to give THC vaping a try.

 

CBD VAPE OIL SAFETY, READ ON…

BENEFITS OF CBD VAPE OIL

3 BIG BENEFITS OF CBD VAPE OIL CARTS, WHY DO THEY WORK?



Source link

Continue Reading

Cannabis News

How to Buy or Sell a Cannabis Business: The Webinar Replay

Published

on

By


For anyone who wasn’t able to join us on April 17th, the video replay of our webinar titled “How to Buy or Sell a Cannabis Business” is now available on our website. You can view it here.

The description of this webinar is also included directly below. Enjoy!

____

On Wednesday, April 17, 2024 at 12:00 pacific time, Harris Sliwoski managing partner Vince Sliwoski (Portland), Harris Sliwoski partner Griffen Thorne (Los Angeles), and Andy Shelley of CannXperts will present a free webinar entitled “How to Buy or Sell a Cannabis Business.”

Drawing on their extensive experience from representing businesses and entrepreneurs across numerous M&A transactions, including crucial state license transfers throughout the United States, our panelists will share insights and practical wisdom from their firsthand experiences in the legal cannabis industry.

  • Crafting and understanding Letters of Intent
  • Conducting thorough Due Diligence
  • Drafting and Negotiating purchase agreements and ancillary documents
  • Navigating State-Specific Regulatory Concerns
  • Managing Escrow Challenges
  • Optimizing Financial Arrangements: Purchase Prices, Holdbacks, Earnouts
  • Tackling Post-Closing Considerations

As always, we’ll also take Q&A, so please feel free to either submit questions when registering or you will be able to ask comments in chat during the webinar.



Source link

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media